In the News
Advocacy is an activity by an individual or group which aims to influence decisions within political, economic, and social systems and institutions.
WHAT WE ARE WORKING ON
Our Latest News: Read about
our work in action.
PABS Letter to Presidency_11 March
Honourable President Ramaphosa, We write out of deep concern about the final round of negotiations for the Pathogen Access and Benefit Sharing (PABS) system taking place 23-28 March 2026 at the World Health Organisation. The PABS system will be formalised as an annex to the WHO Pandemic Agreement...
Public Voices Rise
The Cancer Alliance represented by SECTION27 returned to court today in the matter of Cancer Alliance v the MEC for Health, Gauteng and 10 others. Today’s proceedings concerned an application for leave to appeal instituted by the provincial health respondents in the matter after a judgment...
Celgene Flagged
For overpricing bone marrow cancer drug The Competition Commission has referred for prosecution to the Competition Tribunal (“Tribunal”), international drug manufacturer Celgene Corporation...
Cancer Alliance Tackles Price Gouging
Represented by SECTION27, takes on multinational company Cancer Alliance tackles price gouging 14 November 2024, Johannesburg - The Cancer Alliance, represented by SECTION27, has been admitted by the Competition Tribunal as an intervening party in the excessive pricing case initiated by the...
Lenalidomide Price Case Progress
Access to Medicine: Lenalidomide Cancer Alliance submitted a case for the investigation of excessive pricing for lenalidomide to the South African Competition Commission in January 2023. The CompCom confirmed their intention to investigate this case in February 2023. Appendix A, 2024-02-06, Tbls...
Sa’s Medicine Patent Laws Must Be Changed
– INTERVIEW SALOME MEYER https://youtu.be/IygOCleU1Z4 SABC TV interviewed Salome Meyer from the Cancer Alliance on the problems around the cost of cancer medications, particularly Herceptin (trastuzumab), an important drug used for certain types of breast cancer.
Categories
CANCER ALLIANCE PUBLISHES SECTION 2 OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: AWARENESS AND PREVENTION
Breast Cancer Control Policy 2017 26th November 2018 The Cancer Alliance today continues its series on the Breast Cancer Control Policy with Section 2: Awareness and Prevention. South Africa’s new Breast Cancer Control Policy is a vital document...
CANCER ALLIANCE PUBLISHES THE FIRST SECTION OF THE ADVOCACY TOOLKIT ON THE NEW BREAST CANCER POLICY: THE NEW POLICY
Breast Cancer Prevention and Control Policy 2017 The Cancer Alliance today publishes the first in a new series on the Breast Cancer Prevention and Control Policy 2017. South Africa’s new Breast Cancer Prevention and Control Policy is a vital...
NATIONAL CANCER CAMPAIGN LAUNCH 30 OCTOBER 2018
PRESS RELEASE: NATIONAL CANCER CAMPAIGN For immediate release. Kindly redistribute as widely as possible! 30th October 2018: The National Cancer Campaign (NCC), announced by President Cyril Ramaphosa on 16 February, 2018 will be...
CANCER ALLIANCE PUBLISHES SECTION 4 OF THE ADVOCACY TOOLKIT ON THE NEW PALLIATIVE CARE POLICY: STORIES OF HOPE, CARE AND SURVIVAL
National Policy Framework and Strategy for Palliative Care 2017-2022 The Cancer Alliance today releases the fourth and last in its series on the new National Policy Framework and Strategy for Palliative Care 2017-2022 - Section 4: Stories of Hope,...
CANCER ALLIANCE PUBLISHES IMPORTANT NEW STUDY ON BREAST CANCER AND TRASTUZUMAB ACCESS IN SOUTH AFRICA
The Cancer Alliance today publishes an important new study BREAST CANCER and HER2+ BREAST CANCER WITH A LOOK AT TRASTUZUMAB ACCESS IN SOUTH AFRICA. Breast cancer is the most common cancer in South Africa. It is also the second highest cancer killer...
FIRST BIOSIMILAR DRUG APPROVED IN SOUTH AFRICA BUT PRICE IS STILL HIGH
Teva Pharmaceutical Industries has obtained approval to sell the first biosimilar drug Filgrastim Teva in South Africa Business Day today reports that Teva Pharmaceutical Industries has become the first company to have a biosimilar drug...
CANCER ALLIANCE PUBLISHES SECTION 3 OF THE ADVOCACY TOOLKIT ON THE NEW PALLIATIVE CARE POLICY: CANCER AND CHILDREN
National Policy Framework and Strategy for Palliative Care 2017-2022 The Cancer Alliance today releases the third in its series on the new National Policy Framework and Strategy for Palliative Care 2017-2022 - Section 3: Cancer and Children....
VISION CANCER NEWSLETTER – JUNE 2018
[icon name="eye" class="" unprefixed_class=""] VISION Newsletter for June 2018 In this month's issue: New SA Intellectual Property Policy approved - Support for prostate cancer patients on the East Rand - Fighting fake medicines around the world -...
CANCER ALLIANCE PUBLISHES SECTION 2 OF THE ADVOCACY TOOLKIT ON THE NEW PALLIATIVE CARE POLICY: ADULTS WITH CANCER
National Policy Framework and Strategy for Palliative Care 2017-2022 The Cancer Alliance today releases the second in its series on the new National Policy Framework and Strategy for Palliative Care 2017-2022 - Section 2: Adults with Cancer....
VISION CANCER NEWSLETTER – MAY 2018
[icon name="eye" class="" unprefixed_class=""] VISION Newsletter for May 2018 In this month's issue: Have your say on the new draft tobacco legislation - Phoenix North Coast Cancer Support Group partnership to provide free cancer screening - Price...
SA CABINET APPROVES NEW INTELLECTUAL PROPERTY (IP) POLICY
The Fix the Patent Laws Coalition (FTPL) welcomes the news today that the Cabinet of the Government of South Africa has approved the new Intellectual Property (IP) Policy. After nine years of policy development, two different draft policies and...
IN LOVING MEMORY OF SUE JOHNSON (04/04/1954 – 16/05/2018)
It is with immense sadness that the Fix the Patent Laws (FTPL) Coalition shares the news of the passing of a dear friend and brave patient advocate, Sue Johnson. Sue was a mother of two children and grandmother to two girls. She was born in the UK...